Deep brain stimulation (DBS) is often used in refractory cases of Parkinson’s disease as well as in a number of other movement disorders. Electrodes are placed in deep nuclei of the brain ...

are planning to develop a new kind of brain implant from small clusters of brain cells to treat Parkinson’s disease. This approach, as detailed in a university statement from January 23 ...

Degeneration of this structure is characteristic of Parkinson's disease. In late 2018, Japanese neurosurgeons at Kyoto University Hospital implanted reprogrammed stem cells into the brain of a ...

Different models on the development of Parkinson's disease might represent a disease largely triggered by something in our environment, hinting at ways of preventing a significant number of cases.

More information: Junguang Wu et al, A nanoparticle-based wireless deep brain stimulation system that reverses Parkinson's disease, Science Advances (2025). DOI: 10.1126/sciadv.ado4927 ...

The FDA approved a monthly maintenance dosing of intravenous lecanemab (Leqembi) for early Alzheimer's disease, said ...

ABL Bio’s first-in-class bispecific antibodies for Parkinson’s disease combine unprecedented blood–brain barrier penetration ... shows no cross-reactivity with other SNCA homologs in vitro ...

SAN FRANCISCO—While deep-brain stimulation therapy has been available for people with Parkinson’s disease for decades, Medtronic has now received a European approval for what it describes as ...

Researchers at Tel Aviv University (TAU) discovered a new factor in the pathology of Parkinson's disease ... the brain, affecting one cell after another, and gradually destroying whole sections ...